<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Approach to the adult with nausea and vomiting</title><link href="/z/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/z/d/css/icofont.min.css" rel="stylesheet"/><link href="/z/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/z/d/css/animate.css" rel="stylesheet"/><link href="/z/d/css/owl.carousel.css" rel="stylesheet"/><link href="/z/d/css/magnific-popup.css" rel="stylesheet"/><link href="/z/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/z/d/css/style.css" rel="stylesheet"/><link href="/z/d/css/rtl_edited.css" rel="stylesheet"/><link href="/z/d/css/responsive.css" rel="stylesheet"/><link href="https:///uptodate_assets/main.css" rel="stylesheet"/>
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>
<meta content="" name="description"/>
<link href="/z/d/img/favicon.png" rel="icon" type="image/png">
</link></head>
<body>
<!-- Start Main Menu Area -->
<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>
<section class="teacher-area ptb-10">
<div class="container">
</div>
<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Approach to the adult with nausea and vomiting</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="topicTitle">Approach to the adult with nausea and vomiting</div> <div class="authorSectionElem"><div class="authorsElementsLeft"><dl id="topicContributors"><dt><span> </span>Author:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">George F Longstreth, MD</a></dd><dt><span> </span>Section Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Nicholas J Talley, MD, PhD</a></dd><dt><span> </span>Deputy Editor:</dt><dd><a class="contributor contributor_credentials" rel="noopener noreferrer" target="_blank">Shilpa Grover, MD, MPH, AGAF</a></dd></dl></div><div class="authorsElementsRight"><div id="literatureReviewDate"><div class="litReviewSingleLine"><bdi><span class="emphasis">Literature review current through:</span> Jan 2024.</bdi></div><div class="litReviewSingleLine"><bdi><span class="emphasis">This topic last updated:</span> May 31, 2022.</bdi></div></div></div></div><div id="topicWhatsNewContainer"></div><div id="topicText"><p class="headingAnchor" id="H1"><span class="h1">INTRODUCTION</span><span class="headingEndMark"> — </span>Nausea, the unpleasant sensation of being about to vomit, can occur alone or can accompany vomiting (the forceful expulsion of gastric contents), dyspepsia, or other gastrointestinal symptoms. Nausea can occur without vomiting and, less commonly, vomiting occurs without nausea. Nausea is often more bothersome and disabling than vomiting. Retching differs from vomiting in the absence of expulsion of gastric content. In addition, patients may confuse vomiting with regurgitation, which is the return of esophageal contents to the hypopharynx with little effort [<a href="#rid1">1</a>]. (See  <a class="medical medical_review" href="/z/d/html/2265.html" rel="external">"Clinical manifestations and diagnosis of gastroesophageal reflux in adults"</a>.)</p><p>The recommendations made in this topic are generally consistent with the American Gastroenterological Association (AGA) guidelines for nausea and vomiting [<a href="#rid2">2</a>]. The pathophysiology of nausea and vomiting and the overall approach to the patient with these symptoms will be reviewed here. The prevention and treatment of chemotherapy-induced nausea and vomiting and characteristics of antiemetic drugs are discussed separately. (See  <a class="medical medical_review" href="/z/d/html/1151.html" rel="external">"Prevention of chemotherapy-induced nausea and vomiting in adults"</a> and  <a class="medical medical_review" href="/z/d/html/2538.html" rel="external">"Characteristics of antiemetic drugs"</a>.)</p><p class="headingAnchor" id="H2"><span class="h1">PATHOPHYSIOLOGY</span><span class="headingEndMark"> — </span>Normal function of the upper gastrointestinal tract involves an interaction between the gut and the central nervous system. The motor function of the gut is controlled at three main levels: the parasympathetic and sympathetic nervous systems; enteric brain neurons; and smooth muscle cells. A discussion of the anatomy and physiology of gastric motor function is discussed separately. (See  <a class="medical medical_review" href="/z/d/html/2638.html" rel="external">"Pathogenesis of delayed gastric emptying"</a>.)</p><p class="headingAnchor" id="H3"><span class="h2">Nausea</span><span class="headingEndMark"> — </span>Gastric rhythm disturbance is a peripheral mechanism underlying nausea from various causes. Nausea correlates with a shift in the normal three cycle per minute gastric myoelectrical activity to increased frequency (tachygastria) or reduced frequency (bradygastria). In motion sickness induced by vection (rotating a drum with black and white vertical stripes around seated stationary subjects), tachygastria precedes nausea, which is proportional to the degree of tachygastria. Drug-induced normalization of tachygastria improves nausea [<a href="#rid1">1,3,4</a>]. </p><p class="headingAnchor" id="H4"><span class="h2">Vomiting</span><span class="headingEndMark"> — </span>Vomiting is a reflex that allows an animal or person to rid itself of ingested toxins or poisons. It can be activated by humoral or neuronal stimuli, or both [<a href="#rid5">5</a>]. Multiple afferent and efferent pathways exist which induce vomiting; the following are the major components of these pathways:</p><p class="bulletIndent1"><span class="glyph">●</span>The area postrema in the floor of the fourth ventricle which contains a "chemoreceptor trigger zone" that is sensitive to many humoral factors, including neurotransmitters, peptides, drugs, and toxins.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>An area in the medulla known as the nucleus tractus solitarius (NTS) which may serve as a central pattern generator for vomiting; information from humoral factors via the area postrema and visceral afferents via the vagus nerve may converge at this site [<a href="#rid6">6</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The central pattern generator presumably projects to the various motor nuclei to elicit the sequential excitation and inhibition that controls the vomiting reflex.</p><p></p><p>Vagal afferent nerves from the gastrointestinal tract synapse in the NTS. From there, some neurons extend to the area postrema; other neurons from the NTS ascend to the paraventricular nuclei of the hypothalamus and the limbic and cortical regions, where gastric electromechanical events are perceived as normal sensations or symptoms such as nausea or discomfort. Afferent sympathetic neurons mediating nociceptive stimuli synapse in the spinal cord and ascend to brainstem nuclei and the hypothalamus  (<a class="graphic graphic_figure graphicRef102412" href="/z/d/graphic/102412.html" rel="external">figure 1</a>).</p><p>The presence of gastrointestinal and multiple nongastrointestinal trigger areas can result in vomiting with numerous disparate disorders  (<a class="graphic graphic_table graphicRef78422" href="/z/d/graphic/78422.html" rel="external">table 1</a>). Five principle neurotransmitter receptors mediate vomiting: muscarinic M1, dopamine D2, histamine H1<sub> </sub>5-hydroxytryptamine (HT)-3 serotonin, and neurokinin 1 (NK1) substance P [<a href="#rid7">7</a>]. (See  <a class="medical medical_review" href="/z/d/html/2538.html" rel="external">"Characteristics of antiemetic drugs"</a>.)</p><p>Studies of vomiting in dogs reveal that gastric content is expelled as a result of gastric and lower esophageal sphincter relaxation, retrograde contraction in the proximal small bowel and antrum, abdominal muscle contraction, and initial cricopharyngeus contraction followed by relaxation seconds before vomiting [<a href="#rid8">8</a>]. Retching occurs when the glottis closes and respiratory muscles counteract abdominal muscle contraction to prevent the expulsion of gastric content.</p><p class="headingAnchor" id="H5"><span class="h1">APPROACH TO MANAGEMENT</span><span class="headingEndMark"> — </span>Patients with acute vomiting, typically for hours to a few days, most often present to an emergency department, whereas patients with chronic symptoms are more often initially evaluated in outpatient office settings. Emergency department physicians should expeditiously exclude life-threatening disorders such as bowel obstruction, mesenteric ischemia, acute pancreatitis, and myocardial infarction  (<a class="graphic graphic_table graphicRef78422" href="/z/d/graphic/78422.html" rel="external">table 1</a>). In both urgent care and routine outpatient settings, the following three steps should generally be undertaken in patients with nausea and vomiting [<a href="#rid1">1</a>].</p><p class="bulletIndent1"><span class="glyph">●</span>The etiology should be sought, taking into account whether the patient has acute nausea and vomiting or chronic symptoms (at least one month in duration) [<a href="#rid9">9</a>].</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The consequences or complications of nausea and vomiting (eg, fluid depletion, hypokalemia, and metabolic alkalosis) should be identified and corrected.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Targeted therapy should be provided, when possible (eg, surgery for bowel obstruction or malignancy). In other cases, the symptoms should be treated.</p><p></p><p class="headingAnchor" id="H558191189"><span class="h2">History and physical examination</span><span class="headingEndMark"> — </span>An initial careful history and physical examination should be performed. In most cases, the cause of the nausea and vomiting can be determined from the history and physical examination and additional testing is not required [<a href="#rid9">9-11</a>]. If additional testing is needed, it should be guided by the symptom duration, frequency, and severity, as well as the characteristics of vomiting episodes and associated symptoms.</p><p>The following clinical features are especially important:</p><p class="bulletIndent1"><span class="glyph">●</span>Drug use can cause nausea and vomiting, particularly opioids and cannabis [<a href="#rid12">12,13</a>]. (See <a class="local">'Functional nausea and vomiting disorders'</a> below.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Abdominal pain with vomiting often indicates an organic etiology (eg, cholelithiasis). (See  <a class="medical medical_review" href="/z/d/html/666.html" rel="external">"Acute calculous cholecystitis: Clinical features and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Abdominal distension and tenderness suggest bowel obstruction. (See  <a class="medical medical_review" href="/z/d/html/8037.html" rel="external">"Etiologies, clinical manifestations, and diagnosis of mechanical small bowel obstruction in adults"</a> and  <a class="medical medical_review" href="/z/d/html/2531.html" rel="external">"Acute colonic pseudo-obstruction (Ogilvie's syndrome)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Vomiting of food eaten several hours earlier and a succussion splash detected on abdominal examination suggest gastric obstruction or gastroparesis. (See  <a class="medical medical_review" href="/z/d/html/2640.html" rel="external">"Gastroparesis: Etiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/2621.html" rel="external">"Gastric outlet obstruction in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Vomiting of blood or coffee ground-like material indicates upper gastrointestinal bleeding. (See  <a class="medical medical_review" href="/z/d/html/2548.html" rel="external">"Approach to acute upper gastrointestinal bleeding in adults"</a>.) </p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Heartburn with nausea often indicates gastroesophageal reflux disease (GERD), and GERD can present as chronic nausea without typical reflux symptoms [<a href="#rid14">14</a>]. (See  <a class="medical medical_review" href="/z/d/html/2265.html" rel="external">"Clinical manifestations and diagnosis of gastroesophageal reflux in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Early morning vomiting is characteristic of pregnancy [<a href="#rid15">15</a>]. (See  <a class="medical medical_review" href="/z/d/html/440.html" rel="external">"Clinical manifestations and diagnosis of early pregnancy"</a> and  <a class="medical medical_review" href="/z/d/html/6811.html" rel="external">"Nausea and vomiting of pregnancy: Treatment and outcome"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Feculent vomiting suggests intestinal obstruction or a gastrocolic fistula. (See  <a class="medical medical_review" href="/z/d/html/8037.html" rel="external">"Etiologies, clinical manifestations, and diagnosis of mechanical small bowel obstruction in adults"</a> and  <a class="medical medical_review" href="/z/d/html/2531.html" rel="external">"Acute colonic pseudo-obstruction (Ogilvie's syndrome)"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Vertigo and nystagmus are typical of vestibular neuritis and other causes of vertigo. (See  <a class="medical medical_review" href="/z/d/html/5102.html" rel="external">"Vestibular neuritis and labyrinthitis"</a> and  <a class="medical medical_review" href="/z/d/html/5101.html" rel="external">"Causes of vertigo"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Bulimia is associated with dental enamel erosion, parotid gland enlargement, lanugo-like hair, and calluses on the dorsal surface of the hand [<a href="#rid16">16-18</a>]. (See  <a class="medical medical_review" href="/z/d/html/2093.html" rel="external">"Eating disorders: Overview of epidemiology, clinical features, and diagnosis"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Headache may indicate migraine-associated vomiting. Neurogenic vomiting may be positional and is usually associated with other neurologic signs or symptoms. (See  <a class="medical medical_review" href="/z/d/html/3348.html" rel="external">"Pathophysiology, clinical manifestations, and diagnosis of migraine in adults"</a> and  <a class="medical medical_review" href="/z/d/html/5180.html" rel="external">"Overview of the clinical features and diagnosis of brain tumors in adults"</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>A similar illness suffered concurrently by people in personal contact with the patient or who had ingested food or liquid from the same source at about the same time suggests a common viral or bacterial pathogen. (See  <a class="medical medical_review" href="/z/d/html/16294.html" rel="external">"Acute viral gastroenteritis in adults"</a> and  <a class="medical medical_review" href="/z/d/html/2689.html" rel="external">"Causes of acute infectious diarrhea and other foodborne illnesses in resource-abundant settings", section on 'Clinical clues to the microbial cause'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Nausea, sometimes with vomiting, can follow passive motion or the visual perception of motion. (See  <a class="medical medical_review" href="/z/d/html/6853.html" rel="external">"Motion sickness"</a>.)</p><p></p><p class="headingAnchor" id="H7"><span class="h2">Endoscopy</span><span class="headingEndMark"> — </span>Most patients with chronic nausea and vomiting that is unexplained after routine evaluation should undergo esophagogastroduodenoscopy to identify gastric obstruction or other disorders that should have specific therapy.</p><p>However, endoscopy and other routine tests are often normal, suggesting an idiopathic (functional) etiology. (See  <a class="medical medical_review" href="/z/d/html/19.html" rel="external">"Functional dyspepsia in adults"</a>.)</p><p class="headingAnchor" id="H3387127984"><span class="h2">Assessment of gastric emptying</span><span class="headingEndMark"> — </span>In patients with chronic nausea and vomiting, if no mechanical obstruction is found by endoscopy, a scintigraphic gastric emptying test or alternative procedure can identify delayed emptying. However, postprandial fullness, early satiation, nausea, and vomiting overlap in patients with functional dyspepsia with or without demonstrated gastroparesis. The usefulness of identifying delayed emptying is further limited by the lability of gastric emptying results over time. For example, of 944 tertiary care patients with chronic upper gastrointestinal symptoms, 42 percent of patients with initial gastroparesis no longer had abnormal emptying 48 months later, and 37 percent of patients with initial normal emptying had gastroparesis at 48 weeks [<a href="#rid19">19</a>]. In addition, there is poor correlation between the severity of delayed emptying and symptom severity, lack of correlation between improvement in gastric emptying and symptom response to prokinetic therapy, and the roles of impaired accommodation and visceral hypersensitivity that are documented by testing that is less widely performed [<a href="#rid20">20,21</a>]. (See  <a class="medical medical_review" href="/z/d/html/2640.html" rel="external">"Gastroparesis: Etiology, clinical manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H558191174"><span class="h1">DIFFERENTIAL DIAGNOSIS</span><span class="headingEndMark"> — </span>Numerous disorders are associated with nausea and vomiting. The following table lists the main causes  (<a class="graphic graphic_table graphicRef78422" data-inline-graphics="78422" href="/z/d/graphic/78422.html" rel="external">table 1</a>).</p><p class="headingAnchor" id="H8"><span class="h1">SPECIFIC DISORDERS</span></p><p class="headingAnchor" id="H9"><span class="h2">Acute disorders</span></p><p class="headingAnchor" id="H10"><span class="h3">Infectious causes</span><span class="headingEndMark"> — </span>Acute gastroenteritis is second only to the common cold as a cause of lost productivity [<a href="#rid22">22</a>]. Bacterial, viral, and parasitic pathogens cause this illness which is characterized by diarrhea and/or vomiting. Vomiting is especially common with infections caused by rotaviruses, enteric adenovirus, norovirus, and <em>Staphylococcus aureus</em>. (See  <a class="medical medical_review" href="/z/d/html/2710.html" rel="external">"Norovirus"</a> and  <a class="medical medical_review" href="/z/d/html/2689.html" rel="external">"Causes of acute infectious diarrhea and other foodborne illnesses in resource-abundant settings", section on 'Vomiting'</a>.)</p><p>Infection with the acute respiratory syndrome coronavirus 2 (SARS-Cov-2) virus (COVID-19) often causes gastrointestinal symptoms, especially diarrhea, abdominal pain, anorexia, nausea, and vomiting, and these symptoms can precede respiratory manifestations. (See  <a class="medical medical_review" href="/z/d/html/128323.html" rel="external">"COVID-19: Clinical features"</a> and  <a class="medical medical_review" href="/z/d/html/127965.html" rel="external">"COVID-19: Issues related to gastrointestinal disease in adults"</a>.)</p><p class="headingAnchor" id="H11"><span class="h3">Postoperative nausea and vomiting</span><span class="headingEndMark"> — </span>About one-third of surgical patients have nausea, vomiting, or both after receiving general anesthesia. Most research has been directed toward prevention rather than therapy of established symptoms [<a href="#rid23">23</a>]. Risk factors include female sex, nonsmoker status, previous history of postoperative nausea and vomiting, and use of postoperative opioids. (See  <a class="medical medical_review" href="/z/d/html/14946.html" rel="external">"Overview of post-anesthetic care for adult patients"</a> and  <a class="medical medical_review" href="/z/d/html/16849.html" rel="external">"Postoperative nausea and vomiting"</a>.)</p><p class="headingAnchor" id="H12"><span class="h3">Vestibular neuritis</span><span class="headingEndMark"> — </span>This acute labyrinthine disorder is characterized by rapid onset of severe vertigo with nausea, vomiting and gait instability. (See  <a class="medical medical_review" href="/z/d/html/5102.html" rel="external">"Vestibular neuritis and labyrinthitis"</a>.)</p><p class="headingAnchor" id="H13"><span class="h3">Chemotherapy-induced nausea and vomiting</span><span class="headingEndMark"> — </span>Nausea and vomiting are common side effects of cancer chemotherapy. Anticipatory antiemetic therapy is indicated when highly emetogenic chemotherapy regimens are given. (See  <a class="medical medical_review" href="/z/d/html/1151.html" rel="external">"Prevention of chemotherapy-induced nausea and vomiting in adults"</a>.)</p><p class="headingAnchor" id="H15"><span class="h2">Chronic disorders</span></p><p class="headingAnchor" id="H16"><span class="h3">Nausea and vomiting of pregnancy</span><span class="headingEndMark"> — </span>Up to 74 percent of pregnant women suffer nausea and/or vomiting, and 50 percent have vomiting alone. Risk factors include low education or income, African-American ancestry, female fetus, increased gravidity, multiple gestation, gestational trophoblastic disease, fetal triploidy, trisomy 21, hydrops fetalis, a personal history of the disorder in a previous pregnancy, and a history of motion sickness, migraine headaches, or nausea associated with use of estrogen-containing contraceptives [<a href="#rid15">15</a>].</p><p>This disorder nearly always begins within the first nine weeks of pregnancy; onset after the initial nine weeks should direct especially careful evaluation for another cause within the differential diagnosis of nausea and vomiting in nonpregnant patients. The diagnosis of hyperemesis gravidarum is applied to the most severely affected patients, up to 1 percent of pregnancies. (See  <a class="medical medical_review" href="/z/d/html/6792.html" rel="external">"Nausea and vomiting of pregnancy: Clinical findings and evaluation"</a>.)</p><p class="headingAnchor" id="H18"><span class="h3">Gastroparesis</span><span class="headingEndMark"> — </span>The term gastroparesis applies to delayed gastric emptying as found from scintigraphic gastric emptying testing or other procedure in the absence of mechanical obstruction. Idiopathic and diabetic gastroparesis are the two most common groups. A noninvasive method of recording gastric myoelectrical activity or slow waves from cutaneous leads placed over the stomach (electrogastrography) reveals abnormalities in some patients, but the role of this procedure in management is uncertain [<a href="#rid20">20</a>]. (See  <a class="medical medical_review" href="/z/d/html/2640.html" rel="external">"Gastroparesis: Etiology, clinical manifestations, and diagnosis"</a> and  <a class="medical medical_review" href="/z/d/html/2532.html" rel="external">"Treatment of gastroparesis"</a>.)</p><p class="headingAnchor" id="H19"><span class="h3">Gastroesophageal reflux</span><span class="headingEndMark"> — </span>Nausea can occasionally be the presenting symptom of gastroesophageal reflux disease and usually responds to management of GERD [<a href="#rid14">14</a>]. (See  <a class="medical medical_review" href="/z/d/html/2265.html" rel="external">"Clinical manifestations and diagnosis of gastroesophageal reflux in adults", section on 'Clinical manifestations'</a> and  <a class="medical medical_review" href="/z/d/html/2258.html" rel="external">"Medical management of gastroesophageal reflux disease in adults"</a>.)</p><p class="headingAnchor" id="H20"><span class="h3">Gastric outlet obstruction</span><span class="headingEndMark"> — </span>Pyloric stenosis can occur from malignancy or peptic ulcer disease. Inflammatory edema associated with ulcers may respond to acid suppression therapy and nasogastric suction. However, fibrotic strictures may persist after ulcer healing. Endoscopic balloon dilation, surgery, and self-expanding metal stenting are treatment options. (See  <a class="medical medical_review" href="/z/d/html/24.html" rel="external">"Overview of complications of peptic ulcer disease"</a> and  <a class="medical medical_review" href="/z/d/html/2621.html" rel="external">"Gastric outlet obstruction in adults"</a>.)</p><p class="headingAnchor" id="H21"><span class="h3">Eosinophilic gastroenteritis</span><span class="headingEndMark"> — </span>Benign eosinophilic infiltration of the gut is uncommon, but its diagnosis is especially important as steroid therapy is usually effective. (See  <a class="medical medical_review" href="/z/d/html/2536.html" rel="external">"Eosinophilic gastrointestinal diseases"</a>.) The disease can occur from the esophagus to the colon, and the symptoms depend upon the extent and layer(s) of bowel involved. Gastric mucosal disease is typically associated with nausea and vomiting. (See  <a class="medical medical_review" href="/z/d/html/2536.html" rel="external">"Eosinophilic gastrointestinal diseases"</a>.)</p><p class="headingAnchor" id="H23"><span class="h3">Chronic idiopathic intestinal pseudo-obstruction</span><span class="headingEndMark"> — </span>Chronic intestinal pseudo-obstruction is usually secondary to an underlying disorder affecting neuromuscular function that suggests mechanical bowel obstruction of the small or large bowel in the absence of an anatomic lesion that obstructs the flow of intestinal contents. (See  <a class="medical medical_review" href="/z/d/html/2639.html" rel="external">"Chronic intestinal pseudo-obstruction: Etiology, clinical manifestations, and diagnosis"</a>.)</p><p class="headingAnchor" id="H2177454374"><span class="h3">Functional nausea and vomiting disorders</span><span class="headingEndMark"> — </span>The Rome IV criteria identify three nausea and vomiting disorders, each of which requires fulfillment of the criteria for at least three months with symptom onset at least six months before diagnosis [<a href="#rid13">13</a>] (see  <a class="medical medical_review" href="/z/d/html/2588.html" rel="external">"Cyclic vomiting syndrome"</a>):</p><p>Chronic nausea and vomiting syndrome (must include all criteria):</p><p class="bulletIndent1"><span class="glyph">●</span>Bothersome (ie, severe enough to impact on usual activities) nausea, occurring at least one day per week and/or one or more vomiting episodes per week.</p><p class="bulletIndent1"><span class="glyph">●</span>Self-induced vomiting, eating disorders, regurgitation, or rumination are excluded.</p><p class="bulletIndent1"><span class="glyph">●</span>No evidence of organic, systemic, or metabolic diseases that is likely to explain the symptoms on routine investigations (including at upper endoscopy).</p><p></p><p>Cyclic vomiting syndrome (Rome IV criteria must include all criteria) [<a href="#rid13">13</a>] (see  <a class="medical medical_review" href="/z/d/html/2588.html" rel="external">"Cyclic vomiting syndrome", section on 'Adult criteria'</a>):</p><p class="bulletIndent1"><span class="glyph">●</span>Stereotypical episodes of vomiting regarding onset (acute) and duration (less than one week).</p><p class="bulletIndent1"><span class="glyph">●</span>At least three discrete episodes in the prior year and two episodes in the past six months, occurring at least one week apart. </p><p class="bulletIndent1"><span class="glyph">●</span>Absence of vomiting between episodes, but other milder symptoms can be present between cycles</p><p class="bulletIndent1"><span class="glyph">●</span>A history or family history of migraine headaches further supports the diagnosis.</p><p class="bulletIndent1"><span class="glyph">●</span>The American Neurogastroenterology and Motility Society and Cyclic Vomiting Association characterize a typical four-phase cycle [<a href="#rid24">24</a>]: </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Prodrome of intense nausea, sometimes with panic symptoms, diarrhea, cold and hot flashes, and profuse sweating; </p><p class="bulletIndent2"><span class="glyph">•</span>Vomiting/retching phase, sometimes with migraine headache, photosensitivity, and phonosensitivity; </p><p class="bulletIndent2"><span class="glyph">•</span>Recovery phase lasting hours to days; and </p><p class="bulletIndent2"><span class="glyph">•</span>Inter-episodic phase. </p><p></p><p>Cannabinoid hyperemesis syndrome (must include all criteria):</p><p class="bulletIndent1"><span class="glyph">●</span>Stereotypical episodic vomiting resembling cyclic vomiting syndrome in terms of onset, duration, and frequency.</p><p class="bulletIndent1"><span class="glyph">●</span>Presentation after prolonged excessive cannabis use.</p><p class="bulletIndent1"><span class="glyph">●</span>Relief of vomiting episodes by sustained cessation of cannabis use.</p><p class="bulletIndent1"><span class="glyph">●</span>Supportive remarks:</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>May be associated with pathologic bathing behavior (prolonged hot baths or showers).</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Following a systematic literature review, Venkatesan et al proposed these criteria be modified to require at least three episodes per year, cannabis use for greater than one year before symptom onset and average use greater than four times per week, and resolution after cessation of cannabis use for at least six months or at least equal to a duration that spans three typical cycles in the patient [<a href="#rid25">25</a>].</p><p></p><p class="headingAnchor" id="H24"><span class="h3">Rumination syndrome</span><span class="headingEndMark"> — </span>The rumination syndrome is distinct from vomiting, but misdiagnosis as vomiting, gastroparesis, or gastroesophageal reflux disease is common. It is a behavioral disorder that is most commonly identified among mentally-disadvantaged children, although it is increasingly recognized among adolescents and adults of normal mental capacity. </p><p>According to the Rome IV criteria, the diagnosis of rumination syndrome requires the presence of all of the following criteria for at least three months (with symptom onset at least six months prior to diagnosis) [<a href="#rid13">13</a>]:</p><p class="bulletIndent1"><span class="glyph">●</span>Persistent or recurrent regurgitation of recently ingested food into the mouth with subsequent spitting or remastication and swallowing</p><p class="bulletIndent1"><span class="glyph">●</span>Regurgitation is not preceded by retching</p><p></p><p>Supportive remarks:</p><p class="bulletIndent1"><span class="glyph">●</span>Effortless regurgitation events are usually not preceded by nausea</p><p class="bulletIndent1"><span class="glyph">●</span>Regurgitant contains recognizable food that might have a pleasant taste</p><p class="bulletIndent1"><span class="glyph">●</span>The process tends to cease when the regurgitated material becomes acidic</p><p></p><p>The primary treatment is behavioral modification, principally using diaphragmatic breathing techniques. (See  <a class="medical medical_review" href="/z/d/html/113568.html" rel="external">"Rumination syndrome", section on 'Management'</a>.)</p><p class="headingAnchor" id="H25"><span class="h1">TREATMENT</span><span class="headingEndMark"> — </span>The management of acute and chronic nausea and vomiting may differ, and vomiting can be more responsive than nausea [<a href="#rid1">1</a>]. Drug treatment is standard practice. Dietary interventions and the treatment of hypovolemia are discussed elsewhere. (See  <a class="medical medical_review" href="/z/d/html/2532.html" rel="external">"Treatment of gastroparesis", section on 'Dietary modification'</a> and  <a class="medical medical_review" href="/z/d/html/2296.html" rel="external">"Maintenance and replacement fluid therapy in adults"</a> and  <a class="medical medical_review" href="/z/d/html/1607.html" rel="external">"Treatment of severe hypovolemia or hypovolemic shock in adults"</a>.)</p><p class="headingAnchor" id="H26"><span class="h2">Drug therapy</span><span class="headingEndMark"> — </span>Few high-quality therapeutic trials have compared the efficacy of different drugs in patients presenting acutely with nausea and vomiting. A systematic review identified eight randomized clinical trials in patients presenting to emergency departments, of which three trials compared a single dose of drugs with placebo and reported the primary outcome as the change in visual analogue scale for nausea severity from baseline to 30 minutes. <a class="drug drug_general" data-topicid="9642" href="/z/d/drug information/9642.html" rel="external">Metoclopramide</a> (three trials), <a class="drug drug_general" data-topicid="9719" href="/z/d/drug information/9719.html" rel="external">ondansetron</a> (two trials), <a class="drug drug_general" data-topicid="9816" href="/z/d/drug information/9816.html" rel="external">prochlorperazine</a> (one trial), and <a class="drug drug_general" data-topicid="9395" href="/z/d/drug information/9395.html" rel="external">droperidol</a> (one trial) were tested, and only droperidol in a study of 48 participants revealed a significant improvement compared with placebo. Acute gastroenteritis is the most common underlying disorder in patients seeking emergency department care, but participants had various etiologies for their symptoms, limiting the usefulness of these studies in guiding therapy of patients with specific causes [<a href="#rid26">26</a>]. In many patients, treatment is based upon patient preference, costs, and safety.</p><p class="headingAnchor" id="H558191836"><span class="h3">Antiemetics and prokinetics</span><span class="headingEndMark"> — </span>Acute or chronic nausea and vomiting can often be helped by antiemetic or prokinetic drugs [<a href="#rid27">27</a>]. The antiemetic drug therapy generally recommended varies according to the etiology  (<a class="graphic graphic_table graphicRef78749" href="/z/d/graphic/78749.html" rel="external">table 2</a>). The efficacy of the available prokinetic drugs is limited [<a href="#rid1">1</a>]. (See  <a class="medical medical_review" href="/z/d/html/2538.html" rel="external">"Characteristics of antiemetic drugs"</a>.)</p><p class="bulletIndent1"><span class="glyph">●</span><a class="drug drug_general" data-topicid="9816" href="/z/d/drug information/9816.html" rel="external">Prochlorperazine</a> is an antiemetic that often partially alleviates acute nausea and vomiting (eg, acute gastroenteritis), but is associated with risks of hypotension and extrapyramidal side effects. Prochlorperazine should usually be considered in such cases before trying serotonin receptor antagonists or prokinetic drugs.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The dopamine receptor antagonist, <a class="drug drug_general" data-topicid="9642" href="/z/d/drug information/9642.html" rel="external">metoclopramide</a>, has combined antiemetic and prokinetic properties. However, it can be associated with extrapyramidal side effects. It can be given orally or intravenously. When given intravenously, using a slow infusion over 15 minutes is associated with a lower incidence of akathisia compared with bolus dosing, without a decrease in efficacy [<a href="#rid28">28</a>].</p><p></p><p class="bulletIndent1">Another dopamine antagonist, <a class="drug drug_general" data-topicid="8777" href="/z/d/drug information/8777.html" rel="external">domperidone</a>, penetrates the blood-brain barrier poorly. As a result, anxiety and dystonia are much less common than with <a class="drug drug_general" data-topicid="9642" href="/z/d/drug information/9642.html" rel="external">metoclopramide</a>. Domperidone is not approved for use in the United States. However, the Food and Drug Administration has encouraged "physicians who would like to prescribe domperidone for their patients with severe gastrointestinal disorders that are refractory to standard therapy to open an Investigational New Drug Application." The FDA domperidone investigational new drug section can be contacted at <a class="__cf_email__" data-cfemail="f5b19a988590879c919a9b90bcbbb1b5939194db9d9d86db929a83" href="/cdn-cgi/l/email-protection">[email protected]</a>. (See  <a class="medical medical_review" href="/z/d/html/2532.html" rel="external">"Treatment of gastroparesis", section on 'Domperidone'</a>.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Agents with mainly prokinetic properties include <a class="drug drug_general" data-topicid="9418" href="/z/d/drug information/9418.html" rel="external">erythromycin</a> (motilin receptor agonist) and <a class="drug drug_general" data-topicid="9153" href="/z/d/drug information/9153.html" rel="external">bethanechol</a> (muscarinic receptor agonist).</p><p></p><p class="bulletIndent1"><a class="drug drug_general" data-topicid="9418" href="/z/d/drug information/9418.html" rel="external">Erythromycin</a> has a narrow therapeutic window, above which abdominal pain and nausea are common. Thus, it can improve gastric emptying without improving nausea. A systematic review of published clinical trials of oral erythromycin therapy for various types of gastroparesis revealed that all studies were methodologically weak and that improvement occurred in fewer than 50 percent of patients [<a href="#rid29">29</a>].</p><p></p><p class="bulletIndent1">The side effects of <a class="drug drug_general" data-topicid="9153" href="/z/d/drug information/9153.html" rel="external">bethanechol</a> are similar to those of <a class="drug drug_general" data-topicid="9418" href="/z/d/drug information/9418.html" rel="external">erythromycin</a>, and trial data are even more limited.</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>The serotonin antagonists form the cornerstone of therapy for the control of acute emesis with chemotherapy agents and can also be used for other causes of nausea and vomiting  (<a class="graphic graphic_table graphicRef78749" href="/z/d/graphic/78749.html" rel="external">table 2</a>). (See  <a class="medical medical_review" href="/z/d/html/2538.html" rel="external">"Characteristics of antiemetic drugs", section on 'Serotonin receptor antagonists'</a> and  <a class="medical medical_review" href="/z/d/html/1151.html" rel="external">"Prevention of chemotherapy-induced nausea and vomiting in adults", section on '5-HT3 receptor antagonists'</a>.)</p><p></p><p class="headingAnchor" id="H558191844"><span class="h3">Antidepressants</span><span class="headingEndMark"> — </span>Tricyclic antidepressants (eg, <a class="drug drug_general" data-topicid="8605" href="/z/d/drug information/8605.html" rel="external">amitriptyline</a>) have a role both as abortive treatment and as prophylaxis for cyclic vomiting syndrome [<a href="#rid24">24</a>]. (See  <a class="medical medical_review" href="/z/d/html/2588.html" rel="external">"Cyclic vomiting syndrome", section on 'Abortive medications (for prodrome)'</a> and  <a class="medical medical_review" href="/z/d/html/2588.html" rel="external">"Cyclic vomiting syndrome", section on 'Prophylactic medications'</a>.)</p><p class="headingAnchor" id="H27"><span class="h2">Gastric electrical stimulation</span><span class="headingEndMark"> — </span>Gastric electrical stimulation via implanted electrodes has been applied to highly selected patients with gastroparesis that is refractory to conventional therapy. A device is available in the United States for humanitarian use, and open-label studies in patients with gastroparesis of various etiologies have found benefit. However, results of controlled trials in patients with diabetic or idiopathic gastroparesis are conflicting, and there are no published trials in patients with chronic unexplained nausea and vomiting with normal gastric emptying [<a href="#rid30">30</a>]. (See  <a class="medical medical_review" href="/z/d/html/2578.html" rel="external">"Electrical stimulation for gastroparesis"</a>.)</p><p class="headingAnchor" id="H28"><span class="h2">Surgical therapy</span><span class="headingEndMark"> — </span>Gastrostomy, pyloroplasty, jejunostomy, and gastrectomy have been performed in patients with postsurgical, diabetic, and idiopathic gastroparesis, but the reports were uncontrolled, unblinded, and retrospective, and the benefit was unconvincing, except possibly for completion gastrectomy in patients with postsurgical gastroparesis [<a href="#rid31">31,32</a>]. (See  <a class="medical medical_review" href="/z/d/html/2532.html" rel="external">"Treatment of gastroparesis"</a>.)</p><p class="headingAnchor" id="H1869639107"><span class="h1">SOCIETY GUIDELINE LINKS</span><span class="headingEndMark"> — </span>Links to society and government-sponsored guidelines from selected countries and regions around the world are provided separately. (See  <a class="medical medical_society_guidelines" href="/z/d/html/116020.html" rel="external">"Society guideline links: Nausea and vomiting"</a>.)</p><p class="headingAnchor" id="H1911717072"><span class="h1">INFORMATION FOR PATIENTS</span><span class="headingEndMark"> — </span>UpToDate offers two types of patient education materials, "The Basics" and "Beyond the Basics." The Basics patient education pieces are written in plain language, at the 5<sup>th</sup> to 6<sup>th</sup> grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10<sup>th</sup> to 12<sup>th</sup> grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.</p><p>Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on "patient info" and the keyword(s) of interest.) </p><p class="bulletIndent1"><span class="glyph">●</span>Basics topics (see  <a class="medical medical_basics" href="/z/d/html/15733.html" rel="external">"Patient education: Nausea and vomiting in adults (The Basics)"</a> and  <a class="medical medical_basics" href="/z/d/html/15732.html" rel="external">"Patient education: Upper endoscopy (The Basics)"</a> and  <a class="medical medical_basics" href="/z/d/html/16731.html" rel="external">"Patient education: Motion sickness (The Basics)"</a>)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span>Beyond the Basics topics (see  <a class="medical medical_patient" href="/z/d/html/1992.html" rel="external">"Patient education: Upper endoscopy (Beyond the Basics)"</a>)</p><p></p><p class="headingAnchor" id="H29"><span class="h1">SUMMARY AND RECOMMENDATIONS</span></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Pathophysiology</strong> – Nausea, the unpleasant sensation of being about to vomit, can occur alone or can accompany vomiting (the forceful expulsion of gastric contents), dyspepsia, or other gastrointestinal symptoms. Retching differs from vomiting in the absence of expulsion of gastric content. In addition, patients may confuse vomiting with regurgitation, which is the return of esophageal contents to the hypopharynx with little effort. (See <a class="local">'Pathophysiology'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Etiology</strong> – A variety of disorders can produce nausea with or without vomiting  (<a class="graphic graphic_table graphicRef78422" href="/z/d/graphic/78422.html" rel="external">table 1</a>). The diverse differential diagnosis of nausea and vomiting should be approached initially with a careful history and physical examination. (See <a class="local">'Differential diagnosis'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Evaluation</strong> – In most cases, the cause of the nausea and vomiting can be determined from the history and physical examination and additional testing is not required (eg, in a patient with a history and examination suggestive of gastroenteritis). (See <a class="local">'History and physical examination'</a> above.)</p><p></p><p class="bulletIndent1">Testing should be guided by the symptom duration, frequency, and severity, as well as the characteristics of vomiting episodes and associated symptoms. Most patients with chronic nausea and vomiting that is unexplained should undergo esophagogastroduodenoscopy to identify disorders that should have specific therapy. In patients with chronic nausea and vomiting, if no mechanical obstruction is found by endoscopy, a scintigraphic gastric emptying test or alternative procedure can identify delayed emptying. (See <a class="local">'Endoscopy'</a> above and <a class="local">'Assessment of gastric emptying'</a> above.)</p><p></p><p class="bulletIndent1"><span class="glyph">●</span><strong>Management</strong> </p><p></p><p class="bulletIndent2"><span class="glyph">•</span>The consequences or complications of nausea and vomiting (eg, fluid depletion, hypokalemia, and metabolic alkalosis) should be identified and corrected.</p><p></p><p class="bulletIndent2"><span class="glyph">•</span>Therapy should be directed at the underlying etiology when possible (eg, surgery for bowel obstruction or malignancy). In other cases, symptoms should be treated. Few high-quality therapeutic trials have compared the efficacy of different drugs in specified types of nausea and vomiting. However, acute or chronic nausea and vomiting may be helped by antiemetic or prokinetic drugs depending upon the underlying cause  (<a class="graphic graphic_table graphicRef78749" href="/z/d/graphic/78749.html" rel="external">table 2</a>). (See <a class="local">'Treatment'</a> above.)</p><p></p></div><div class="headingAnchor" id="references"><ol id="reference"><li><a class="nounderline abstract_t">Singh P, Yoon SS, Kuo B. Nausea: a review of pathophysiology and therapeutics. Therap Adv Gastroenterol 2016; 9:98.</a></li><li><a class="nounderline abstract_t">American Gastroenterological Association. American Gastroenterological Association medical position statement: nausea and vomiting. Gastroenterology 2001; 120:261.</a></li><li><a class="nounderline abstract_t">Koch KL, Stern RM, Vasey MW, et al. Neuroendocrine and gastric myoelectrical responses to illusory self-motion in humans. Am J Physiol 1990; 258:E304.</a></li><li><a class="nounderline abstract_t">Koch KL. Gastric dysrhythmias: a potential objective measure of nausea. Exp Brain Res 2014; 232:2553.</a></li><li><a class="nounderline abstract_t">Carpenter DO. Neural mechanisms of emesis. Can J Physiol Pharmacol 1990; 68:230.</a></li><li><a class="nounderline abstract_t">Hornby PJ. Central neurocircuitry associated with emesis. Am J Med 2001; 111 Suppl 8A:106S.</a></li><li><a class="nounderline abstract_t">Bashashati M, McCallum RW. Neurochemical mechanisms and pharmacologic strategies in managing nausea and vomiting related to cyclic vomiting syndrome and other gastrointestinal disorders. Eur J Pharmacol 2014; 722:79.</a></li><li><a class="nounderline abstract_t">Lang IM, Sarna SK, Dodds WJ. Pharyngeal, esophageal, and proximal gastric responses associated with vomiting. Am J Physiol 1993; 265:G963.</a></li><li><a class="nounderline abstract_t">Metz A, Hebbard G. Nausea and vomiting in adults--a diagnostic approach. Aust Fam Physician 2007; 36:688.</a></li><li><a class="nounderline abstract_t">Scorza K, Williams A, Phillips JD, Shaw J. Evaluation of nausea and vomiting. Am Fam Physician 2007; 76:76.</a></li><li><a class="nounderline abstract_t">Lacy BE, Parkman HP, Camilleri M. Chronic nausea and vomiting: evaluation and treatment. Am J Gastroenterol 2018; 113:647.</a></li><li><a class="nounderline abstract_t">Bollom A, Austrie J, Hirsch W, et al. Emergency Department Burden of Nausea and Vomiting Associated With Cannabis Use Disorder: US Trends From 2006 to 2013. J Clin Gastroenterol 2018; 52:778.</a></li><li><a class="nounderline abstract_t">Stanghellini V, Chan FK, Hasler WL, et al. Gastroduodenal Disorders. Gastroenterology 2016; 150:1380.</a></li><li><a class="nounderline abstract_t">Brzana RJ, Koch KL. Gastroesophageal reflux disease presenting with intractable nausea. Ann Intern Med 1997; 126:704.</a></li><li><a class="nounderline abstract_t">Herrell HE. Nausea and vomiting of pregnancy. Am Fam Physician 2014; 89:965.</a></li><li><a class="nounderline abstract_t">Harrington BC, Jimerson M, Haxton C, Jimerson DC. Initial evaluation, diagnosis, and treatment of anorexia nervosa and bulimia nervosa. Am Fam Physician 2015; 91:46.</a></li><li><a class="nounderline abstract_t">Sim LA, McAlpine DE, Grothe KB, et al. Identification and treatment of eating disorders in the primary care setting. Mayo Clin Proc 2010; 85:746.</a></li><li><a class="nounderline abstract_t">Hermont AP, Oliveira PA, Martins CC, et al. Tooth erosion and eating disorders: a systematic review and meta-analysis. PLoS One 2014; 9:e111123.</a></li><li><a class="nounderline abstract_t">Pasricha PJ, Grover M, Yates KP, et al. Functional Dyspepsia and Gastroparesis in Tertiary Care are Interchangeable Syndromes With Common Clinical and Pathologic Features. Gastroenterology 2021; 160:2006.</a></li><li><a class="nounderline abstract_t">Tack J, Wald A. Gastroparesis: Time for a Reappraisal? Gastroenterology 2015; 149:1666.</a></li><li><a class="nounderline abstract_t">Tack J, Schol J, Horowitz M. Gastroparesis: A Dead-end Street After All? Gastroenterology 2021; 160:1931.</a></li><li><a class="nounderline abstract_t">Moffet HL. Common infections in ambulatory patients. Ann Intern Med 1978; 89:743.</a></li><li><a class="nounderline abstract_t">Cao X, White PF, Ma H. An update on the management of postoperative nausea and vomiting. J Anesth 2017; 31:617.</a></li><li><a class="nounderline abstract_t">Venkatesan T, Levinthal DJ, Tarbell SE, et al. Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association. Neurogastroenterol Motil 2019; 31 Suppl 2:e13604.</a></li><li><a class="nounderline abstract_t">Venkatesan T, Levinthal DJ, Li BUK, et al. Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome. Neurogastroenterol Motil 2019; 31 Suppl 2:e13606.</a></li><li><a class="nounderline abstract_t">Furyk JS, Meek RA, Egerton-Warburton D. Drugs for the treatment of nausea and vomiting in adults in the emergency department setting. Cochrane Database Syst Rev 2015; :CD010106.</a></li><li><a class="nounderline abstract_t">Furyk JS, Meek R, McKenzie S. Drug treatment of adults with nausea and vomiting in primary care. BMJ 2014; 349:g4714.</a></li><li><a class="nounderline abstract_t">Tura P, Erdur B, Aydin B, et al. Slow infusion metoclopramide does not affect the improvement rate of nausea while reducing akathisia and sedation incidence. Emerg Med J 2012; 29:108.</a></li><li><a class="nounderline abstract_t">Maganti K, Onyemere K, Jones MP. Oral erythromycin and symptomatic relief of gastroparesis: a systematic review. Am J Gastroenterol 2003; 98:259.</a></li><li><a class="nounderline abstract_t">Wo JM, Nowak TV, Waseem S, Ward MP. Gastric Electrical Stimulation for Gastroparesis and Chronic Unexplained Nausea and Vomiting. Curr Treat Options Gastroenterol 2016; 14:386.</a></li><li><a class="nounderline abstract_t">Jones MP, Maganti K. A systematic review of surgical therapy for gastroparesis. Am J Gastroenterol 2003; 98:2122.</a></li><li><a class="nounderline abstract_t">Hibbard ML, Dunst CM, Swanström LL. Laparoscopic and endoscopic pyloroplasty for gastroparesis results in sustained symptom improvement. J Gastrointest Surg 2011; 15:1513.</a></li></ol></div><div id="topicVersionRevision">Topic 2537 Version 27.0</div></div>
<div class="row">
<div class="col-12">
<h4 style="text-align: center;padding: 20px;color: cadetblue;">References</h4>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26770271" id="rid0" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>1 : Nausea: a review of pathophysiology and therapeutics.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11208735" id="rid1" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>2 : American Gastroenterological Association medical position statement: nausea and vomiting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2137678" id="rid2" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>3 : Neuroendocrine and gastric myoelectrical responses to illusory self-motion in humans.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24916149" id="rid3" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>4 : Gastric dysrhythmias: a potential objective measure of nausea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/2178747" id="rid4" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>5 : Neural mechanisms of emesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/11749934" id="rid5" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>6 : Central neurocircuitry associated with emesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/24161560" id="rid6" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>7 : Neurochemical mechanisms and pharmacologic strategies in managing nausea and vomiting related to cyclic vomiting syndrome and other gastrointestinal disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/7902012" id="rid7" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>8 : Pharyngeal, esophageal, and proximal gastric responses associated with vomiting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17885699" id="rid8" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>9 : Nausea and vomiting in adults--a diagnostic approach.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/17668843" id="rid9" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>10 : Evaluation of nausea and vomiting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29545633" id="rid10" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>11 : Chronic nausea and vomiting: evaluation and treatment.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/29095419" id="rid11" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>12 : Emergency Department Burden of Nausea and Vomiting Associated With Cannabis Use Disorder: US Trends From 2006 to 2013.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27147122" id="rid12" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>13 : Gastroduodenal Disorders.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/9139556" id="rid13" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>14 : Gastroesophageal reflux disease presenting with intractable nausea.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25162163" id="rid14" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>15 : Nausea and vomiting of pregnancy.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25591200" id="rid15" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>16 : Initial evaluation, diagnosis, and treatment of anorexia nervosa and bulimia nervosa.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/20605951" id="rid16" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>17 : Identification and treatment of eating disorders in the primary care setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25379668" id="rid17" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>18 : Tooth erosion and eating disorders: a systematic review and meta-analysis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33548234" id="rid18" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>19 : Functional Dyspepsia and Gastroparesis in Tertiary Care are Interchangeable Syndromes With Common Clinical and Pathologic Features.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26505820" id="rid19" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>20 : Gastroparesis: Time for a Reappraisal?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/33621562" id="rid20" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>21 : Gastroparesis: A Dead-end Street After All?</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/717946" id="rid21" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>22 : Common infections in ambulatory patients.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/28455599" id="rid22" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>23 : An update on the management of postoperative nausea and vomiting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31241819" id="rid23" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>24 : Guidelines on management of cyclic vomiting syndrome in adults by the American Neurogastroenterology and Motility Society and the Cyclic Vomiting Syndrome Association.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/31241817" id="rid24" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>25 : Role of chronic cannabis use: Cyclic vomiting syndrome vs cannabinoid hyperemesis syndrome.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/26411330" id="rid25" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>26 : Drugs for the treatment of nausea and vomiting in adults in the emergency department setting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/25103458" id="rid26" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>27 : Drug treatment of adults with nausea and vomiting in primary care.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21292793" id="rid27" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>28 : Slow infusion metoclopramide does not affect the improvement rate of nausea while reducing akathisia and sedation incidence.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/12591038" id="rid28" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>29 : Oral erythromycin and symptomatic relief of gastroparesis: a systematic review.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/27678506" id="rid29" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>30 : Gastric Electrical Stimulation for Gastroparesis and Chronic Unexplained Nausea and Vomiting.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/14572555" id="rid30" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>31 : A systematic review of surgical therapy for gastroparesis.</p>
</a>
</div>
<div class="col-12" style="text-align: left;direction: ltr">
<a href="https://pubmed.ncbi.nlm.nih.gov/21720926" id="rid31" target="_blank">
<p class="btn-info round" style='width: 100%;margin-bottom: 5px !important;padding: 10px;border-radius: 12px;;font-family: Arial, "Helvetica Neue", Helvetica, sans-serif;'>32 : Laparoscopic and endoscopic pyloroplasty for gastroparesis results in sustained symptom improvement.</p>
</a>
</div>
</div>
</div>
</div>
</section>
</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->
<!-- End Footer Area -->
<!-- Back to top -->
<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->
<!-- Prpper JS -->
<!-- Bootstrap Min JS -->
<!-- Classy Nav Min Js -->
<!-- Owl Carousel Min Js -->
<!-- Magnific Popup JS -->
<!-- CounterUp JS -->
<!-- Waypoints JS -->
<!-- Form Validator Min JS -->
<!-- Contact Form Min JS -->
<!-- Main JS -->
<!-- Global site tag (gtag.js) - Google Analytics -->
</body>
</html>
